Advertisement
U.S. markets closed

Enlivex Therapeutics Ltd. (ENLV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.0400-0.1100 (-3.49%)
At close: 04:00PM EST
3.0100 -0.03 (-0.99%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close3.1500
Open3.2000
Bid3.0000 x 2200
Ask3.0500 x 800
Day's Range2.8400 - 3.3000
52 Week Range1.2000 - 4.0300
Volume75,549
Avg. Volume96,018
Market Cap56.54M
Beta (5Y Monthly)0.99
PE Ratio (TTM)N/A
EPS (TTM)-1.4700
Earnings DateApr 01, 2024 - Apr 05, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ENLV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Enlivex Therapeutics Ltd.
    Daily – Vickers Top Buyers & Sellers for 01/12/2024The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more